nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Systems-Level View of Renal Metabolomics
|
Rhee, Eugene P. |
|
2018 |
38 |
2 |
p. 142-150 |
artikel |
2 |
Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease
|
Li, Daniel Y. |
|
2018 |
38 |
2 |
p. 193-205 |
artikel |
3 |
Editorial Board
|
|
|
2018 |
38 |
2 |
p. A1 |
artikel |
4 |
Genome-Wide Association Studies of Metabolite Concentrations (mGWAS): Relevance for Nephrology
|
Köttgen, Anna |
|
2018 |
38 |
2 |
p. 151-174 |
artikel |
5 |
Introduction: Systems Biology of Kidney Disease
|
Sharma, Kumar |
|
2018 |
38 |
2 |
p. 99-100 |
artikel |
6 |
Lipidomics and Biomarker Discovery in Kidney Disease
|
Afshinnia, Farsad |
|
2018 |
38 |
2 |
p. 127-141 |
artikel |
7 |
Masthead
|
|
|
2018 |
38 |
2 |
p. IFC |
artikel |
8 |
Metabolomics and Metabolic Reprogramming in Kidney Cancer
|
Weiss, Robert H. |
|
2018 |
38 |
2 |
p. 175-182 |
artikel |
9 |
Mitochondrial Dysfunction and Signaling in Diabetic Kidney Disease: Oxidative Stress and Beyond
|
Flemming, Nicole Bernadette |
|
2018 |
38 |
2 |
p. 101-110 |
artikel |
10 |
Table of Contents
|
|
|
2018 |
38 |
2 |
p. A2 |
artikel |
11 |
Targeting Glucosylceramide Synthesis in the Treatment of Rare and Common Renal Disease
|
Shayman, James A. |
|
2018 |
38 |
2 |
p. 183-192 |
artikel |
12 |
The Role of Peroxisome Proliferator-Activated Receptor γ Coactivator 1α (PGC-1α) in Kidney Disease
|
Li, Szu-Yuan |
|
2018 |
38 |
2 |
p. 121-126 |
artikel |
13 |
The Warburg Effect in Diabetic Kidney Disease
|
Zhang, Guanshi |
|
2018 |
38 |
2 |
p. 111-120 |
artikel |